POSA108 A Budget Impact Analysis of Atezolizumab Monotherapy for First Line Treatment of Patients with PD-L1 High Metastatic NSCLC in Italy
- Resource Type
- Abstract
- Source
- In
Value in Health January 2022 25(1) Supplement:S54-S54 - Subject
- Language
- ISSN
- 1098-3015